Showing results (591-600 of 834) with videos related to

Sort By:
Pageof 84
JAMA Network Open|September 10, 2025
Critical Care Physicians' Perspectives on Nudging in CommunicationDerek R Soled, Christy L Cummings, Laura M Berbert, et al.
Alzheimer'S Research & Therapy|January 9, 2025
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's diseaseJeffrey L Cummings, Alireza Atri, Howard H Feldman, et al.
American Journal of Clinical Oncology|October 9, 2025
A Cost-effectiveness Analysis of Adjuvant Alectinib in Patients With Resectable ALK-positive Non-small Cell Lung Cancer in the United StatesAmy L Cummings, Jesse Sussell, Katherine L Rosettie, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's diseaseD L Sultzer, M E Mahler, M A Mandelkern, et al.
Current Medical Research and Opinion|August 23, 2025
Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer's diseaseJared Stroud, Jeffrey L Cummings, Sanjeda R Chumki, et al.
Lung Cancer (Amsterdam, Netherlands)|August 14, 2025
A treatment-impact model of alectinib for the prediction of recurrence and associated costs in treating resectable ALK+ non-small cell lung cancerAmy L Cummings, Jesse Sussell, Katherine L Rosettie, et al.
JCO Precision Oncology|September 10, 2025
Identification of Targetable EGFR Mutations in Ovarian CancerArjan Gower, Susan Win, Rituparna Ganguly, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|April 1, 1997
Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric AssociationP F Malloy, J L Cummings, C E Coffey, et al.
JAMA|January 11, 2018
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical TrialsAlireza Atri, Lutz Frölich, Clive Ballard, et al.
Brain and Language|May 9, 2007
3D mapping of language networks in clinical and pre-clinical Alzheimer's diseaseLiana G Apostolova, Po Lu, Steve Rogers, et al.
Pageof 84